Related Experiment Videos
Failure to engraft after bone marrow transplantation: bone marrow morphologic findings
1Institute of Pathology, Case Western Reserve University, Cleveland, OH 44106.
American Journal of Clinical Pathology
|December 1, 1994
Summary
Delayed engraftment after bone marrow transplantation (BMT) in four patients was linked to hypocellular marrow and increased histiocytes. This finding suggests a potential association with certain immune deficiencies and blood disorders.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Limited research exists on bone marrow findings in graft failure or delayed engraftment post-bone marrow transplantation (BMT).
- Understanding these findings is crucial for managing BMT complications.
Purpose of the Study:
- To investigate bone marrow characteristics in patients experiencing delayed engraftment after BMT.
- To identify potential associations between specific bone marrow findings and delayed hematopoietic recovery.
Main Methods:
- Retrospective analysis of bone marrow examinations from 4 out of 165 BMT recipients with delayed peripheral blood count recovery.
- Review of patient demographics, transplant types, indications, post-transplant treatments, and biopsy timing.
- Microscopic examination of bone marrow aspirate smears and biopsies, including special stains (acid-fast, GMS).
Main Results:
- All four patients presented with markedly hypocellular bone marrow aspirates and biopsies.
- Histiocytes with foamy eosinophilic cytoplasm were diffusely present in all biopsies.
- Delayed engraftment occurred between 19 and 40 days post-BMT, with low white cell, hematocrit, and platelet counts.
- Negative acid-fast and GMS stains ruled out certain infections; serous fat atrophy and marrow fibrosis were absent.
Conclusions:
- Delayed engraftment following BMT may be associated with a prominent histiocytic proliferation.
- This histiocytic proliferation pattern resembles findings in immunodeficiency, hematologic disorders, and storage diseases.
- Further research is warranted to elucidate the mechanisms and clinical significance of this bone marrow finding in BMT recipients.